Stock ADVENZYMES ADVANCED ENZYME TECHNOLOGIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Advanced Enzyme Technologies Limited

Equities

ADVENZYMES

INE837H01020

Specialty Chemicals

Market Closed - NSE India S.E.
Other stock markets
 07:43:53 2024-07-12 am EDT 		5-day change 1st Jan Change
376.4 INR -1.32% Intraday chart for Advanced Enzyme Technologies Limited -5.71% +0.28%
May. 15 Transcript : Advanced Enzyme Technologies Limited, Q4 2024 Earnings Call, May 15, 2024
May. 11 Advanced Enzyme Technologies Limited Declares an Interim Dividend for the Financial Year 2024-2025, Payable on or Before June 5, 2024 CI

Valuation

Fiscal Period: Marzo 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 15,914 38,541 31,539 25,943 38,965 42,091 -
Enterprise Value (EV) 1 15,914 38,541 31,539 25,943 38,965 42,091 42,091
P/E ratio 12.3 x 26.4 x 26.4 x 24.6 x 29.2 x 23.5 x 19.9 x
Yield - 0.26% 0.35% 0.43% - 0.53% 0.53%
Capitalization / Revenue 3.58 x 7.68 x 5.96 x 4.8 x - 6 x 5.34 x
EV / Revenue 3.58 x 7.68 x 5.96 x 4.8 x - 6 x 5.34 x
EV / EBITDA 7.65 x 16.6 x 15.7 x 16.6 x - 17.8 x 15.4 x
EV / FCF - 26.9 x 33.1 x 25.3 x - 14.6 x 20 x
FCF Yield - 3.72% 3.03% 3.95% - 6.87% 5%
Price to Book 1.9 x 3.97 x 2.9 x 2.1 x - 2.85 x 2.52 x
Nbr of stocks (in thousands) 111,678 111,728 111,801 111,824 111,824 111,824 -
Reference price 2 142.5 345.0 282.1 232.0 348.4 376.4 376.4
Announcement Date 5/30/20 5/29/21 5/20/22 5/13/23 5/11/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,440 5,018 5,294 5,406 - 7,014 7,888
EBITDA 1 2,080 2,315 2,014 1,564 - 2,368 2,742
EBIT - - - - - - -
Operating Margin - - - - - - -
Earnings before Tax (EBT) 1 1,792 2,104 1,711 1,404 - 2,394 2,816
Net income 1 1,293 1,462 1,196 1,056 1,333 1,797 2,114
Net margin 29.12% 29.13% 22.59% 19.54% - 25.62% 26.8%
EPS 2 11.56 13.07 10.68 9.450 11.92 16.00 18.90
Free Cash Flow 1 - 1,435 954.2 1,024 - 2,892 2,105
FCF margin - 28.59% 18.02% 18.95% - 41.23% 26.69%
FCF Conversion (EBITDA) - 61.96% 47.37% 65.48% - 122.13% 76.77%
FCF Conversion (Net income) - 98.13% 79.79% 96.97% - 160.93% 99.57%
Dividend per Share 2 - 0.9000 1.000 1.000 - 2.000 2.000
Announcement Date 5/30/20 5/29/21 5/20/22 5/13/23 5/11/24 - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - 1,435 954 1,024 - 2,892 2,105
ROE (net income / shareholders' equity) 17% 15.1% 11% 8.71% - 12.1% 16%
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 75.20 86.90 97.40 110.0 - 132.0 149.0
Cash Flow per Share - - - - - - -
Capex 1 - 194 269 379 - 300 300
Capex / Sales - 3.87% 5.08% 7.02% - 4.28% 3.8%
Announcement Date 5/30/20 5/29/21 5/20/22 5/13/23 5/11/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
376.4 INR
Average target price
470 INR
Spread / Average Target
+24.87%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
ADVANCED ENZYME TECHNOLOGIES LIMITED Stock Advanced Enzyme Technologies Limited
+0.28% 504M
ECOLAB INC. Stock Ecolab Inc.
+24.08% 70.28B
SIKA AG Stock Sika AG
-3.00% 47.63B
GIVAUDAN SA Stock Givaudan SA
+25.57% 45.14B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+34.90% 29.06B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.71% 19.18B
SYMRISE AG Stock Symrise AG
+15.37% 17.52B
CELANESE CORPORATION Stock Celanese Corporation
-8.45% 15.54B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-23.96% 15.38B
NITTO DENKO CORPORATION Stock Nitto Denko Corporation
+26.68% 11.88B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. ADVENZYMES Stock
  4. Financials Advanced Enzyme Technologies Limited